Skip to content

Absorbable Suture Versus Tissue Glue to Repair Defects Following Mohs Surgery

Fast Absorbing Gut Suture Versus Cyanoacrylate Tissue Adhesive in the Epidermal Closure of Linear Repairs Following Mohs Micrographic Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01298167
Enrollment
14
Registered
2011-02-17
Start date
2011-02-28
Completion date
2012-08-31
Last updated
2012-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Basal Cell Carcinoma, Squamous Cell Carcinoma

Keywords

Cyanoacrylate, Fast Absorbing Gut, Mohs Surgery, Epidermal closure method

Brief summary

The purpose of the study is to look at which nonpermanent superficial closure method, cyanoacrylate tissue glue or fast absorbing gut suture, leads to a better cosmetic and functional outcome in repairs of facial wounds after Mohs surgery.

Detailed description

Cyanoacrylate is a rapidly polymerizing topical adhesive commonly used as an alternative to traditional sutures. Both cyanoacrylate and fast absorbing gut suture eliminate the need for suture removal which can represent a significant savings in patient and staff time as well as related healthcare resources. Both cyanoacrylate and fast absorbing gut suture are currently routinely used for epidermal closure at Yale following Mohs micrographic surgery. Physician preference currently dictates which epidermal closure method is chosen for a given surgery. Cyanoacrylate has been reported to decrease trauma to the epidermal edges, minimize suture tract marks in surgical scars, and decrease the risk of inflammatory reaction to suture material. Cyanoacrylate, however, does not allow for wound eversion. Wound eversion minimizes the risk of a depressed scar from tissue contraction during healing. As with all sutures, fast absorbing gut suture allows for wound eversion which is reported to maximize the likelihood of a good epidermal approximation. On the other hand, fast absorbing gut suture degrades by proteolysis which can result in an inflammatory reaction. Any inflammatory reaction on the skin while healing can affect the final cosmetic outcome (ie. post-inflammatory hyperpigmentation). A recent article (Tierney 2009), reported that tissue adhesive may not be as effective in achieving optimal cosmesis as fast absorbing gut for defects on the trunk and extremities. However, we would like to study these two methods for the repair of facial wounds, which are in low tension areas as compared to trunk and extremities. Therefore, it is unknown exactly which of these two method is better than the other in epidermal closure of facial wounds follow Mohs micrographic surgery.

Interventions

DEVICECyanoacrylate tissue glue versus Fast absorbing gut

All wounds will be closed using a linear, bilayered closure method, where the buried intradermal absorbing suture (5-0, Polysorb) will be placed along the length of the incision, consistent with standard surgical procedure. Only patients with wounds with a length of 3cm or greater will be enrolled. Each wound will be measured, and the length divided in half. Half of the surgical wound will be randomly selected (by coin toss) for epidermal reapproximation with cyanoacrylate, whereas the other half will be repaired with 6-0 fast absorbing gut suture in standard running fashion.

Sponsors

Yale University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* The subject is willing and able to give informed consent. * The subject is willing and able to participate in the study as an outpatient and is willing to comply with study requirements. * The subject is 18 years of age or older. * The subject has a diagnosis of a non-melanoma skin cancer on the face requiring Mohs micrographic surgery. * The subjects also has a final wound length of 3cm or greater. * The subject is able to abide by the protocol of standard postoperative care and is able to attend standard post-operative visits at 3 months after the surgery.

Exclusion criteria

* The subject is on systemic immunosuppressants and/or is an organ transplant recipients. * The subject has reported or suspected hypersensitivity to cyanoacrylate or fast absorbing gut suture. * The subject has a dermatologic disease in the target site that may interfere with examination.

Design outcomes

Primary

MeasureTime frameDescription
Visual Analog Scale (VAS)3 monthsThe Visual Analog or Analogue Scale (VAS)\* is designed to present to the respondent a rating scale with minimum constraints. Respondents mark the location on the 10-centimeter line corresponding to their feeling. It also gives the maximum opportunity for each respondent to express a personal response style. The scale is interpreted as the greater the scale score (as the score approaches 10), the greater the cosmetic and functional outcome of the healed wound. * Aitken, R. C. B. (1969). Measurement of feelings using visual analogue scales. Proceedings of the Royal Society of Medicine. 62, 989 - 993 * Freyd, M. (1923). The graphic rating scale. Journal of Educational Psychology, 43, 83 - 102 * Hayes, M. H. S. & D. G. Patterson (1921). Experimental development of the graphic rating method. Psychological Bulletin, 18, 98-99

Countries

United States

Participant flow

Participants by arm

ArmCount
Cyanoacrylate Superior ½ of Wound & FAG Inferior ½ of Wound
Patients wounds were divided in half and Cyanoacrylate was utilized for the superior ½ of the wound & Fast Acting Gut Suture was utilized for inferior ½ of wound.
6
FAG Superior ½ of Wound & Cyanoacrylate Inferior ½ of Wound
Patients wounds were divided in half and Fast Acting Gut Suture was utilized for the superior ½ of the wound & Cyanoacrylate was utilized for inferior ½ of wound.
8
Total14

Baseline characteristics

CharacteristicFAG Superior ½ of Wound & Cyanoacrylate Inferior ½ of WoundTotalCyanoacrylate Superior ½ of Wound & FAG Inferior ½ of Wound
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
3 Participants7 Participants4 Participants
Age, Categorical
Between 18 and 65 years
5 Participants7 Participants2 Participants
Sex: Female, Male
Female
2 Participants4 Participants2 Participants
Sex: Female, Male
Male
6 Participants10 Participants4 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 60 / 8
serious
Total, serious adverse events
0 / 60 / 8

Outcome results

Primary

Visual Analog Scale (VAS)

The Visual Analog or Analogue Scale (VAS)\* is designed to present to the respondent a rating scale with minimum constraints. Respondents mark the location on the 10-centimeter line corresponding to their feeling. It also gives the maximum opportunity for each respondent to express a personal response style. The scale is interpreted as the greater the scale score (as the score approaches 10), the greater the cosmetic and functional outcome of the healed wound. * Aitken, R. C. B. (1969). Measurement of feelings using visual analogue scales. Proceedings of the Royal Society of Medicine. 62, 989 - 993 * Freyd, M. (1923). The graphic rating scale. Journal of Educational Psychology, 43, 83 - 102 * Hayes, M. H. S. & D. G. Patterson (1921). Experimental development of the graphic rating method. Psychological Bulletin, 18, 98-99

Time frame: 3 months

Population: Individuals' wounds were divided in half and then treated with both Cyanoacrylate and Fast Absorbing Gut Suture. Individuals were randomized as to which half of the wound (superior or inferior) would be treated by each of the methods.

ArmMeasureValue (MEAN)Dispersion
Cyanoacrylate Superior/InferiorVisual Analog Scale (VAS)7.47 units on a scaleStandard Deviation 0.81
FAG Superior/InferiorVisual Analog Scale (VAS)7.97 units on a scaleStandard Deviation 1.25

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026